Contemporary Diagnosis and Management of Patients with MINOCA
- PMID: 37067753
- PMCID: PMC10188585
- DOI: 10.1007/s11886-023-01874-x
Contemporary Diagnosis and Management of Patients with MINOCA
Abstract
Purpose of review: Myocardial infarction with nonobstructive coronary arteries (MINOCA) is defined as acute myocardial infarction (MI) with angiographically no obstructive coronary artery disease or stenosis ≤ 50%. MINOCA is diagnostically challenging and complex, making it difficult to manage effectively. This condition accounts for 6-8% of all MI and poses an increased risk of morbidity and mortality after diagnosis. Prompt recognition and targeted management are essential to improve outcomes and our understanding of this condition, but this process is not yet standardized. This article offers a comprehensive review of MINOCA, delving deep into its unique clinical profile, invasive and noninvasive diagnostic strategies for evaluating MINOCA in light of the lack of widespread availability for comprehensive testing, and current evidence surrounding targeted therapies for patients with MINOCA.
Recent findings: MINOCA is not uncommon and requires comprehensive assessment using various imaging modalities to evaluate it further. MINOCA is a heterogenous working diagnosis that requires thoughtful approach to diagnose the underlying disease responsible for MINOCA further.
Keywords: CMD; INOCA; MINOCA; Microvascular disease; PET; Stress CMR; VSA.
© 2023. The Author(s).
Conflict of interest statement
NBM receives consulting fees from iRhythm and SHL Telemedicine. MG served on an advisory board for Novartis and was a speaker for Siemens Healthcare Diagnostics. She is a co-investigator and site PI of the Women’s Ischemia Trial to Reduce Events In Non-Obstructive CAD (WARRIOR) Study funded by the Department of Defense (Award Number: W81XWH-17–2-0030) and a co-investigator of the Women Ischemic Syndrome Evaluation (WISE) Study funded by the NHLBI. She is also the president of the American Society for Preventive Cardiology (unpaid). JW served on an advisory board for Abbott Vascular (paid to institution). PP received payment or honoraria from AstraZeneca and participated on a Data Safety Monitoring Board or Advisory Board for Medtronic.
Figures
References
-
- •• Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):E891-E908. 10.1161/CIR.0000000000000670/FORMAT/EPUB. This study is important because it was the first scientific statement from AHA that described the diagnostic approach to patients presenting with MINOCA. - PubMed
-
- • Pasupathy S, Lindahl B, Litwin P, et al. Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration. Circ Cardiovasc Qual Outcomes. 2021;14(11):e007880. 10.1161/CIRCOUTCOMES.121.007880/FORMAT/EPUB. This study is important because it shows that MINOCA, a condition previously dismissed as benign, has increased risk of adverse outcomes compared to healthy subjects but had a favorable prognosis compared to MI-CAD. - PubMed
-
- Agewall S, Beltrame JF, Reynolds HR, et al. Current opinion ESC working group position paper on myocardial infarction with non-obstructive coronary arteries on behalf of the WG on Cardiovascular Pharmacotherapy. 10.1093/eurheartj/ehw149. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
